Cerebral hemodynamics and metabolism in patients with symptomatic occlusion of the internal carotid artery

Stroke

Volumn 34, Issue 3, 2003, Pages 648-652

  Rutgers, D R ^a   Van Osch, M J P ^b   Kappelle, L J ^a   Mali, W P T M ^a   Van der Grond, J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Carotid artery diseases; Choline; Creatine; Hemodynamics; N acetyl aspartate; Occlusion

Indexed keywords

CARBON DIOXIDE; CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN PERFUSION; CLINICAL ARTICLE; DOPPLER ECHOGRAPHY; FEMALE; HEMISPHERE; HEMODYNAMICS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MALE; NERVE INJURY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETINA ISCHEMIA; VASOMOTOR REFLEX; WHITE MATTER;

ASPARTIC ACID; BLOOD FLOW VELOCITY; BRAIN; CAROTID ARTERY DISEASES; CAROTID ARTERY, INTERNAL; CEREBROVASCULAR CIRCULATION; CHOLINE; CREATINE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURONS; REFERENCE VALUES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 0037335933     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000058158.41581.41     Document Type: Article

References (34)

1. Hankey GJ, Warlow CP. Prognosis of symptomatic carotid artery occlusion. Cerebrovasc Dis. 1991;1:245-256.
2. Klijn CJM, Kappelle LJ, Tulleken CAF, van Gijn J. Symptomatic carotid artery occlusion: a reappraisal of hemodynamic factors. Stroke. 1997;28:2084-2093.
3. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA. 1998;280:1055-1060.
4. Klijn CJM, Kappelle LJ, Van der Grond J, Algra A, Tulleken CAF, van Gijn J. Magnetic resonance techniques for the identification of patients with symptomatic carotid artery occlusion at high risk of cerebral ischemic events. Stroke. 2000;31:3001-3007.
5. Tsuchida C, Kimura H, Sadato N, Tsuchida T, Tokuriki Y, Yonekura Y. Evaluation of brain metabolism in steno-occlusive carotid artery disease by proton MR spectroscopy: a correlative study with oxygen metabolism by PET. J Nucl Med. 2000;41:1357-1362.
6. Van der Grond J, van Everdingen KJ, Eikelboom BC, Kenez J, Mali WPTM. Assessment of borderzone ischemia with a combined MR imaging-MR angiography-MR spectroscopy protocol. J Magn Reson Imaging. 1999;9:1-9.
7. Rutgers DR, Klijn CJM, Kappelle LJ, Van der Grond J. Cerebral metabolic changes in patients with a symptomatic occlusion of the internal carotid artery: a longitudinal 1H magnetic resonance spectroscopy study. J Magn Reson Imaging. 2000;11:279-286.
8. Kauppinen RA, Williams SR. Nuclear magnetic resonance spectroscopy studies of the brain. Prog Neurobiol. 1994;44:87-118.
9. Welch KM, Levine SR, Martin G, Ordidge RJ, Vande Linde AM, Helpern JA. Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin. 1992:10:1-29.
10. Miller BL. A review in chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991;4:47-52.
11. Saunders DE, Howe FA, van den Boogaart A, McLean MA, Griffiths JR, Brown MM. Continuing ischemic damage after acute middle cerebral artery infarction in humans demonstrated by short-echo proton spectroscopy. Stroke. 1995;26:1007-1013.
12. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992;31:235-241.
13. Bamford JM, Sandercock PAG, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1989;20:828. Letter.
14. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HBW. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging. 1993;11:107-118.
15. Christiansen P, Toft PB, Gideon P, Danielsen ER, Ring P, Henriksen O. MR-visible water content in human brain: a proton MRS study. Magn Reson Imaging. 1994;12:1237-1244.
16. Rutgers DR, Van der Grond J. Relaxation times of choline, creatine and N-acetyl aspartate in human cerebral white matter at 1.5 T. NMR Biomed. 2002;15:215-221.
17. van Osch MJP, Vonken EJ, Bakker CJG, Viergever MA. Correcting partial volume artifacts of the arterial input function in quantitative cerebral perfusion MRI. Magn Reson Med. 2001;45:477-485.
18. Vonken EPA, Beekman FJ, Bakker CJG, Viergever MA. Maximum likelihood estimation of cerebral blood flow in dynamic susceptibility contrast MRI. Magn Reson Med. 1999;41:343-350.
19. 2-induced cerebral vasomotor response in normal individuals and patients with internal carotid artery occlusions. Stroke. 1988;19:963-969.
20. Keevil SF, Barbiroli B, Brooks JC, Cady EB, Canese R, Carlier P, Collins DJ, Gilligan P, Gobbi G, Hennig J, et al. Absolute metabolite quantification by in vivo NMR spectroscopy. II: a multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging. 1998;16:1093-1106.
21. Valenzuela MJ, Sachdev PS, Wen W, Shnier R, Brodaty H, Gillies D. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage. 2000;12:747-756.
22. Bakker FC, Klijn CJ, Jennekens-Schinkel A, Kappelle LJ. Cognitive disorders in patients with occlusive disease of the carotid artery: a systematic review of the literature. J Neurol. 2000;247:669-676.
23. Derdeyn CP, Grubb RL, Jr, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251-259.
24. Kleiser B, Widder B. Course of carotid artery occlusions with impaired cerebrovascular reactivity. Stroke. 1992;23:171-174.
25. Vernieri F, Pasqualetti P, Passarelli F, Rossini PM, Silvestrini M. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity. Stroke. 1999;30:593-598.
26. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain. 2001;124:457-467.
27. Lythgoe D. Simmons A, Pereira A, Cullinane M, Williams S, Markus HS. Magnetic resonance markers of ischaemia: their correlation with vasodilatory reserve in patients with carotid artery stenosis and occlusion. J Neurol Neurosurg Psychiatry. 2001;71:58-62.
28. Visser GH, Van der Grond J, van Huffelen AC, Wieneke GH, Eikelboom BC. Decreased transcranial Doppler carbon dioxide reactivity is associated with disordered cerebral metabolism in patients with internal carotid artery stenosis. J Vasc Surg. 1999;30:252-260.
29. Derdeyn CP, Videen TO, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. Stroke. 1999;30:1019-1024.
30. Gideon P, Henriksen O, Sperling B, Christiansen P, Olsen TS, Jorgensen HS, Arlien Soborg P. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke. 1992;23:1566-1572.
31. Lin W, Celik A, Derdeyn C, An H, Lee Y, Videen T, Ostergaard L, Powers WJ. Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. J Magn Reson Imaging. 2001;14:659-667.
32. 2O positron emission tomography. Stroke. 2000;31:1958-1964.
33. 2O positron emission tomography in humans. J Cereb Blood Flow Metab. 1998;18:935-940.
34. Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med. 2000;44:466-473.